Stay updated on Daratumumab in Untreated Myeloma: Transplant Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page.

Latest updates to the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page
- Check5 days agoChange DetectedAdded a government funding notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check12 days agoChange DetectedThe history page now includes a 'Show glossary' option and color-coded highlights for additions (green) and deletions (red). The revision note also updates to v3.4.0 and removes the 'No FEAR Act data' entry.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history now shows a new Revision: v3.3.4 entry in place of v3.3.3; this is a minor site versioning update and does not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the list.SummaryDifference0.2%

- Check75 days agoChange DetectedA new revision entry (v3.3.2) was added and the previous revision (v3.2.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe notice about government funding lapse and NIH operating status was removed from the page; it did not affect study data or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Daratumumab in Untreated Myeloma: Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page.